Product

CBP-1008

Name

CBP-1008

1 clinical trial

1 indication

Indication

Advanced Solid Tumor

Clinical trial

A Phase Ia/Ib, Open-Label, Multi-center, First in Human and Expansion Study to Assess the Safety, Tolerance, and Pharmacokinetics of the Novel Antitumor Agent CBP-1008 in Patients With Advanced Solid Tumors

Status: Recruiting, Estimated PCD: 2023-09-01